CAMBRIDGE, MA / ACCESS Newswire / October 19, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced data regarding two of its investigational influenza candidates will be presented at IDWeek 2025, ...

Flu season is here and a covid uptick is around the corner. Two infectious diseases experts offer their tips on how to plan for vaccination against those viruses.

What sets Imunon's technology apart is its rare dual application. The proprietary PlaCCine platform is a non-viral DNA technology being developed to target both infectious diseases and oncology ...

Over the past five years, 800 million people worldwide have been infected with COVID-19. The death toll has reached 7 million. Even now, deaths continue to occur. COVID-19 is now trending toward ...

Discover whether Moderna or BioNTech offers better long-term investment potential as both pivot from COVID-19 to innovative ...

An international research team revealed an innovative vaccine capable of preventing serious immune reactions and ...